by Jordana Choucair | May 23, 2022 | Life Sciences
Pfizer and BioNTech’s COVID-19 vaccine was more than 80 percent effective at eliciting a strong immune response in children between the ages of 6 months and 5 years old. Pfizer is seeking an emergency use authorization to vaccinate children five and under. The...
by Jordana Choucair | May 20, 2022 | Life Sciences
The Centers for Disease Control and Prevention (CDC) recommended a booster dose of the Pfizer-BioNTech Covid-19 vaccine in children ages 5 to 11. The decision came hours after its independent vaccine advisory panel voted 11-1, with one abstention, to recommend the...
by Jordana Choucair | May 20, 2022 | Life Sciences
A group of pharmaceutical companies has partnered with global cancer organizations to create the Access to Oncology Medicines (ATOM) Coalition – an alliance aimed at getting more oncology medications to poorer countries. In addition to providing the drugs, the...
by Jordana Choucair | May 19, 2022 | Life Sciences
President Biden invoked the Defense Production Act to address the baby formula shortage. The act allows the government more control over industrial production during emergencies and will direct suppliers of formula ingredients to prioritize delivery to various...
by Jordana Choucair | May 18, 2022 | Life Sciences
The Food and Drug Administration (FDA) authorized a booster dose of the Pfizer-BioNTech COVID-19 vaccine for children between the ages of 5 and 11. The booster can be administered five months after completion of the primary vaccine series. Data released by Pfizer last...
by Jordana Choucair | May 18, 2022 | Life Sciences
House Appropriations Committee Chairwoman Rosa DeLauro filed supplemental funding legislation to address the nationwide baby formula shortage. The legislation would give the FDA $28 million in emergency funds to address the shortage and prevents future shortages. The...
Recent Comments